Home Cart Sign in  
Chemical Structure| 455-93-6 Chemical Structure| 455-93-6

Structure of 455-93-6

Chemical Structure| 455-93-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 455-93-6 ]

CAS No. :455-93-6
Formula : C7H6FNO3
M.W : 171.13
SMILES Code : O=[N+](C1=CC=C(OC)C(F)=C1)[O-]
MDL No. :MFCD00061095
InChI Key :XGMVTXUXZUPGGY-UHFFFAOYSA-N
Pubchem ID :223104

Safety of [ 455-93-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 455-93-6 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 6
Fraction Csp3 0.14
Num. rotatable bonds 2
Num. H-bond acceptors 4.0
Num. H-bond donors 0.0
Molar Refractivity 41.71
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

55.05 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.42
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.25
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.16
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.86
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.1
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.56

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.56
Solubility 0.475 mg/ml ; 0.00278 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.04
Solubility 0.155 mg/ml ; 0.000908 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.18
Solubility 1.13 mg/ml ; 0.00661 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.75 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.68

Application In Synthesis of [ 455-93-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 455-93-6 ]

[ 455-93-6 ] Synthesis Path-Downstream   1~41

  • 1
  • [ 321-28-8 ]
  • [ 344-78-5 ]
  • [ 455-93-6 ]
  • 2
  • [ 321-28-8 ]
  • [ 455-93-6 ]
YieldReaction ConditionsOperation in experiment
In ethanol; water; acetic anhydride; 2-Fluoro-4-nitroanisole (IX) To a cold (-2), stirred solution of 285 g. (2.26 mol) of 2-fluoroanisole in 1.1 L of acetic anhydride was added, dropwise, 114 mL of fuming nitric acid (sp. gr. 1.59) at such a rate that the reaction temperature remained between -2 and 0. The reaction mixture was stirred for 5 hours at this temperature then poured into 4.0 L of water. The suspension was stirred for 1.5 hours, stored for 15 hours, then extracted with methylene chloride (2*1.0 L). The combined extracts were washed with water (2*500 mL), dried over anhydrous magnesium sulfate, then concentrated in vacuo (475 g.). Crystallization from ethanol gave 147.4 g. (38%) of material suitable for further transformation. Additional material (34.5 g.) was obtained from three scouting runs. Analytically pure product (5.2 g.; 63.4% recovery) was obtained by recrystallizing 8.2 g of the material from 200 mL of ethanol; mp, 105-106 (Literature, R. C. Elderfield et al., J. Am. Chem. Soc., 68, 1584 (1946)). Anal. Calcd for C7 H6 FNO3 (percent): C, 49.13; H, 3.53; F, 11.10; N, 8.19. Found: C, 49.07; H, 3.52; F, 11.02; N, 8.19.
  • 3
  • [ 455-93-6 ]
  • [ 403-19-0 ]
  • 4
  • [ 455-93-6 ]
  • [ 344-78-5 ]
  • 5
  • [ 455-93-6 ]
  • [ 366-99-4 ]
YieldReaction ConditionsOperation in experiment
98% With palladium on activated charcoal; In ethyl acetate; at 20℃; for 1h; 3-Fluoro-4-methoxy-nitrobenzene (0.5 g, 2.9 mmol) was dissolved in ethyl acetate (10 mL) was added palladium on carbon (50 mg), stirred at room temperature for 1 hour. The reaction mixture was filtered, the filtrate was concentrated to give the title compound 3-fluoro-4-methoxyaniline (7B), an off-white solid (0.4 g, 98% yield).
91% With hydrogen;palladium 10% on activated carbon; In ethanol; at 20℃; under 2068.65 Torr; for 4h; To a mixture of 10% Pd/C (1.5 grams) in ethanol (150 mL) taken in a Parr hydrogenation flask was added a solution of <strong>[455-93-6]2-fluoro-4-nitroanisole</strong> (7) (9.09 grams, 53 mmol) in ethanol (150 mL) slowly. The mixture was then stirred under hydrogen atmosphere (40 psi) for 4 hours at room temperature. After completion of the reaction the mixture was filtered through Celite and the residue was washed thoroughly using ethanol (20 mL). The filtrates and washings were collected, combined and evaporated to dryness. The solid obtained was stirred in hexane (50 mL) for 1 hour and filtered to give the desired product 3-fluoro-4-methoxyaniline (8) (6.75 grams).
78% With zinc; In water; at 20℃; for 0.0833333h;Inert atmosphere; General procedure: Under an argon atmosphere, a nitro group-containing compound (0.237 mmol) was weighed into a 5 mL microwave vial containing a magnetic stir bar and a Teflon-lined septum. Subsequently zinc dust (155 mg, 2.37 mmol), ammonium chloride (25 mg, 0.475 mmol) and the aqueous oligosaccharide solution (2 wt % HPMC, 40-60 cps, in degassed Millipore water) were added and the reaction mixture was vigorously stirred at the indicated temperature for the indicated time. The reaction mixture was diluted with ethyl acetate, the solids were filtered and the aqueous phase was extracted 3x with ethyl acetate. The combined organic extracts were dried with magnesium sulfate, filtered and concentrated in vacuo. The crude product was purified by flash chromatography on silica gel.; Following the general procedure using <strong>[455-93-6]2-fluoro-4-nitroanisole</strong> (171 mg, 1.00 mmol), zinc (327 mg, 5.00 mmol), ammonium chloride (64 mg, 1.20 mmol) and 2 ml of aqueous oligosaccharide solution (2 wt % HPMC, 40-60 cps, in degassed Millipore water), the reaction was allowed to stir for 5 min at room temperature. After column chromatography (0-100 % ethyl acetate - dichloromethane), the product was obtained (110 mg, 78 %).ESI-MS: m/z (%): 142.10 (100, [M+H]+).1H NMR (600MHz, d6-OMSO): delta [ppm] : 6.856.31 - 6.28 (m, 1H), 4.91 (sbr, 2H), 3.68 (s, 3H).
palladium-carbon; In 1,4-dioxane; [I] 2 g of 5% palladium carbon was added to a solution prepared by dissolving 10 g of <strong>[455-93-6]4-nitro-2-fluoroanisol</strong> in 150 ml of 1,4-dioxane, and the mixture was subjected to catalytic reduction under a hydrogen gas pressure of 4 kg/cm2 at room temperature for 30 minutes. After the completion of the reaction, palladium carbon was removed by filtration, and the solvent was distilled off under reduced pressure to obtain 8.6 g of 4-amino-2-fluoroanisol.

  • 6
  • [ 455-93-6 ]
  • [ 108-24-7 ]
  • [ 452-15-3 ]
  • 7
  • [ 288-32-4 ]
  • [ 455-93-6 ]
  • [ 636-93-1 ]
  • [ 61292-63-5 ]
  • [ 99-59-2 ]
  • 8
  • [ 288-32-4 ]
  • [ 455-93-6 ]
  • [ 636-93-1 ]
  • 1-(3-Fluoro-4-methoxyphenyl)imidazole [ No CAS ]
  • [ 99-59-2 ]
  • 9
  • [ 67-56-1 ]
  • [ 455-93-6 ]
  • [ 709-09-1 ]
  • [ 636-93-1 ]
  • [ 65739-04-0 ]
  • [ 7501-46-4 ]
  • 10
  • [ 67-56-1 ]
  • [ 455-93-6 ]
  • [ 709-09-1 ]
  • [ 636-93-1 ]
  • [ 7501-46-4 ]
  • [ 124431-92-1 ]
  • 11
  • [ 111-26-2 ]
  • [ 455-93-6 ]
  • [ 709-09-1 ]
  • [ 636-93-1 ]
  • [ 124431-95-4 ]
  • [ 114568-54-6 ]
  • 12
  • [ 111-26-2 ]
  • [ 455-93-6 ]
  • [ 124431-95-4 ]
  • 13
  • [ 111-26-2 ]
  • [ 455-93-6 ]
  • [ 124431-95-4 ]
  • [ 114568-54-6 ]
  • 14
  • [ 111-26-2 ]
  • [ 455-93-6 ]
  • [ 114568-54-6 ]
  • 15
  • [ 100-17-4 ]
  • [ 455-93-6 ]
YieldReaction ConditionsOperation in experiment
73% With xenon difluoride; boron trifluoride diethyl etherate; In acetonitrile; at -35 - 20℃; for 2.5h;Inert atmosphere; General procedure: A three-necked flask equipped with an argon inlet and thermometer was loaded with arene 1 or 3-8 (10 mmol) in dry MeCN (15 mL). Then, BTFE (2.0 g, 14 mmol) was added. The mixture was cooled in the argon stream down to -35 C and XeF2 (2.05 g, 12.5 mmol) was added in small portions. The mixture was warmed to -25 C, stirred for 30 min at this temperature, then heated to 20 C for 1 h, and stirred for additional 1 h (GLC control). A saturated solution of sodium bicarbonate was added to the reaction mass until termination of gas evolution. The resulted mixture was extracted with diethyl ether (3×20 mL). The extract was washed with water and dried with sodium sulfate. In the case of benzene (1), toluene (3), and chlorobenzene (4), the diethyl ether extracts were subjected to molecular distillation and fractionated, each fraction was analyzed by GLC and NMR spectroscopy. In the case of bromobenzene (5), nitrobenzene (6), p-nitrotoluene (7), and p-nitroanisole (8), the ethereal extracts were evaporated in vacuo at the temperature below 25 C, the residue was dissolved in chloroform and subjected to flash chromatography (the eluent was hexane-chloroform, 3 : 1). The eluent was concentrated under normal pressure and the residue was analyzed by NMR spectroscopy. In the case of iodobenzene (15), a precipitate formed upon neutralization with a solution of sodium bicarbonate was filtered, washed with water, sequentially with MeCN (5 mL) and Et2O (5 mL) preserving the filtrate, and dried in air to yield a solid residue (1.1 g), which according to the NMR spectral data was a mixture consisting of (based on the weight percentages) 76% of iodosobenzene (16) and 24% of (4-iodophenyl)phenyliodonium tetrafluoroborate (17). Evaporation of the organic filtrate followed by the treatment of the residue with CHCl3 affords 100 mg of compound 18 with m.p. 149 C (cf. Ref. 17: 147-149 C).
  • 16
  • [ 455-93-6 ]
  • [ 593-51-1 ]
  • [ 636-93-1 ]
  • [ 19871-39-7 ]
  • [ 124431-92-1 ]
  • 17
  • [ 455-93-6 ]
  • [ 593-51-1 ]
  • [ 124431-92-1 ]
  • 18
  • [ 455-93-6 ]
  • [ 623-33-6 ]
  • [ 636-93-1 ]
  • [ 91214-97-0 ]
  • 19
  • [ 455-93-6 ]
  • [ 3844-53-9 ]
  • [ 636-93-1 ]
  • [ 124431-94-3 ]
  • 20
  • [ 455-93-6 ]
  • [ 39978-33-1 ]
  • [ 636-93-1 ]
  • [ 124431-94-3 ]
  • 21
  • [ 455-93-6 ]
  • [ 709-09-1 ]
  • [ 636-93-1 ]
  • [ 65739-04-0 ]
  • [ 7501-46-4 ]
  • 22
  • [ 455-93-6 ]
  • [ 709-09-1 ]
  • [ 636-93-1 ]
  • [ 7501-46-4 ]
  • [ 124431-92-1 ]
  • 23
  • [ 455-93-6 ]
  • [ 636-93-1 ]
  • 1-(3-Fluoro-4-methoxyphenyl)imidazole [ No CAS ]
  • [ 99-59-2 ]
  • 24
  • [ 455-93-6 ]
  • [ 124-40-3 ]
  • [ 709-09-1 ]
  • [ 636-93-1 ]
  • [ 65739-04-0 ]
  • [ 7501-46-4 ]
  • 25
  • [ 455-93-6 ]
  • [ 124-40-3 ]
  • [ 709-09-1 ]
  • [ 636-93-1 ]
  • [ 7501-46-4 ]
  • [ 124431-92-1 ]
  • 26
  • [ 455-93-6 ]
  • [ 109-73-9 ]
  • [ 636-93-1 ]
  • [ 124431-93-2 ]
  • [ 93398-03-9 ]
  • 27
  • [ 455-93-6 ]
  • [ 74-89-5 ]
  • [ 636-93-1 ]
  • [ 19871-39-7 ]
  • [ 124431-92-1 ]
  • 28
  • [ 455-93-6 ]
  • [ 459-73-4 ]
  • [ 636-93-1 ]
  • [ 91214-97-0 ]
  • 29
  • [ 455-93-6 ]
  • [ 75-98-9 ]
  • 2-Methoxy-5-nitrophenyl 2,2-dimethylpropanoate [ No CAS ]
  • 31
  • [ 350-31-2 ]
  • [ 124-41-4 ]
  • [ 455-93-6 ]
  • [ 1009-36-5 ]
  • 33
  • [ 321-28-8 ]
  • [ 455-93-6 ]
  • [ 484-94-6 ]
  • 34
  • 1-(2-methoxy-5-nitrophenyl)-3,3-(1,5-pentanediyl)triazene [ No CAS ]
  • [ 455-93-6 ]
  • 35
  • [ 321-28-8 ]
  • [ 7697-37-2 ]
  • [ 108-24-7 ]
  • [ 455-93-6 ]
  • 36
  • [ 321-28-8 ]
  • [ 7697-37-2 ]
  • [ 344-78-5 ]
  • [ 455-93-6 ]
  • 37
  • [ 7664-93-9 ]
  • [ 455-93-6 ]
  • [ 7697-37-2 ]
  • [ 344-78-5 ]
YieldReaction ConditionsOperation in experiment
20% EXAMPLE 9 Fluorination of 4-Nitroanisole By the method outlined in Example 1, 4-nitroanisole was fluorinated to give 2-fluoro-4-nitroanisole (M+ 171, deltaF -131.6 ppm ?CDCl3!, yield 50%) and 2,6-difluoro-4-nitroanisole (M+ 189, deltaF -125.1 ppm ?CDCl3!, yield 20%). Conversion 60%.
  • 39
  • 4-nitro-anisole-diazopiperidide-(2) [ No CAS ]
  • [ 455-93-6 ]
  • 40
  • 5-nitro-2-methoxy-benzenediazonium-(1)-tetrafluoroborate [ No CAS ]
  • [ 455-93-6 ]
  • 41
  • [ 455-93-6 ]
  • [ 636-93-1 ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 455-93-6 ]

Fluorinated Building Blocks

Chemical Structure| 403-19-0

A173501 [403-19-0]

2-Fluoro-4-nitrophenol

Similarity: 0.92

Chemical Structure| 66684-59-1

A247607 [66684-59-1]

2,3-Difluoro-4-nitroanisole

Similarity: 0.90

Chemical Structure| 22510-08-3

A348054 [22510-08-3]

2-Fluoro-5-nitrophenol

Similarity: 0.89

Chemical Structure| 454-16-0

A199656 [454-16-0]

1-Fluoro-2-methoxy-4-nitrobenzene

Similarity: 0.87

Chemical Structure| 61324-93-4

A446405 [61324-93-4]

1-Fluoro-4-methoxy-2-nitrobenzene

Similarity: 0.87

Ethers

Chemical Structure| 66684-59-1

A247607 [66684-59-1]

2,3-Difluoro-4-nitroanisole

Similarity: 0.90

Chemical Structure| 454-16-0

A199656 [454-16-0]

1-Fluoro-2-methoxy-4-nitrobenzene

Similarity: 0.87

Chemical Structure| 61324-93-4

A446405 [61324-93-4]

1-Fluoro-4-methoxy-2-nitrobenzene

Similarity: 0.87

Chemical Structure| 448-19-1

A310799 [448-19-1]

5-Fluoro-2-nitroanisole

Similarity: 0.86

Chemical Structure| 446-38-8

A312802 [446-38-8]

3-Fluoro-4-nitroanisole

Similarity: 0.85

Nitroes

Chemical Structure| 403-19-0

A173501 [403-19-0]

2-Fluoro-4-nitrophenol

Similarity: 0.92

Chemical Structure| 66684-59-1

A247607 [66684-59-1]

2,3-Difluoro-4-nitroanisole

Similarity: 0.90

Chemical Structure| 22510-08-3

A348054 [22510-08-3]

2-Fluoro-5-nitrophenol

Similarity: 0.89

Chemical Structure| 454-16-0

A199656 [454-16-0]

1-Fluoro-2-methoxy-4-nitrobenzene

Similarity: 0.87

Chemical Structure| 61324-93-4

A446405 [61324-93-4]

1-Fluoro-4-methoxy-2-nitrobenzene

Similarity: 0.87